SBC Medical Group Holdings Incorporated beat EPS estimates 67% of the time across 6 reported quarters (4 beats, 2 misses), averaging +15.0% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $0.12 | $0.10 | -16.7% | Miss | Q2 FY26 call |
| Q1 FY26 | $0.10 | $0.11 | +10.0% | Beat | |
| Q4 FY25 | $0.13 | $0.14 | +7.7% | Beat | |
| Q3 FY25 | $0.13 | $0.12 | -7.7% | Miss | |
| Q2 FY25 | not reported | $0.02 | not reported | not reported | |
| Q1 FY25 | $0.11 | $0.21 | +90.9% | Beat | Q1 FY25 call |
| Q4 FY24 | $0.17 | $0.18 | +5.9% | Beat | |
| Q3 FY24 | not reported | $0.03 | not reported | not reported |
Back to SBC overview · SBC holders · SBC KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.